Measurement and Compartmental Modeling of the Effect of CYP3A5 Gene Variation on Systemic and Intrarenal Tacrolimus Disposition

CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on Tacrolimus dose requirements and clinical outcome after renal transplantation

(2011) François Glowacki et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Expression of CYP3A5 and P-glycoprotein in Renal Allografts With Histological Signs of Calcineurin Inhibitor Nephrotoxicity

(2011) Christoph Metalidis et al.   TRANSPLANTATION

Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II

(2010) Christine E. Staatz et al.   CLINICAL PHARMACOKINETICS

Association between renal function and CYP3A5 genotype in heart transplant recipients treated with calcineurin inhibitors

(2010) Simon de Denus et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Tacrolimus Dose Requirements and CYP3A5 Genotype and the Development of Calcineurin Inhibitor-Associated Nephrotoxicity in Renal Allograft Recipients

(2010) Dirk R J Kuypers et al.   THERAPEUTIC DRUG MONITORING

CYP3A5 *1 Allele: Impacts on Early Acute Rejection and Graft Function in Tacrolimus-Based Renal Transplant Recipients

(2010) Sang-Il Min et al.   TRANSPLANTATION

Effects of Pregnancy on CYP3A and P-glycoprotein Activities as Measured by Disposition of Midazolam and Digoxin: A University of Washington Specialized Center of Research Study

(2008) MF Hebert et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

No Association Between Single Nucleotide Polymorphisms and the Development of Nephrotoxicity After Orthotopic Heart Transplantation

(2008) Bärbel Klauke et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients

(2008) Masahide Fukudo et al.   Pharmacogenetics and Genomics